Literature DB >> 27169690

Mutations in XRCC4 cause primordial dwarfism without causing immunodeficiency.

Shinta Saito1, Aya Kurosawa1,2, Noritaka Adachi1,3.   

Abstract

In successive reports from 2014 to 2015, X-ray repair cross-complementing protein 4 (XRCC4) has been identified as a novel causative gene of primordial dwarfism. XRCC4 is indispensable for non-homologous end joining (NHEJ), the major pathway for repairing DNA double-strand breaks. As NHEJ is essential for V(D)J recombination during lymphocyte development, it is generally believed that abnormalities in XRCC4 cause severe combined immunodeficiency. Contrary to expectations, however, no overt immunodeficiency has been observed in patients with primordial dwarfism harboring XRCC4 mutations. Here, we describe the various XRCC4 mutations that lead to disease and discuss their impact on NHEJ and V(D)J recombination.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27169690     DOI: 10.1038/jhg.2016.46

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  32 in total

1.  Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4.

Authors:  M Bryans; M C Valenzano; T D Stamato
Journal:  Mutat Res       Date:  1999-01-26       Impact factor: 2.433

Review 2.  Functions and regulation of Artemis: a goddess in the maintenance of genome integrity.

Authors:  Aya Kurosawa; Noritaka Adachi
Journal:  J Radiat Res       Date:  2010-06-11       Impact factor: 2.724

3.  Lysine 271 but not lysine 210 of XRCC4 is required for the nuclear localization of XRCC4 and DNA ligase IV.

Authors:  Mikoto Fukuchi; Rujira Wanotayan; Sicheng Liu; Shoji Imamichi; Mukesh Kumar Sharma; Yoshihisa Matsumoto
Journal:  Biochem Biophys Res Commun       Date:  2015-04-28       Impact factor: 3.575

4.  An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome.

Authors:  Christiaan de Bruin; Verónica Mericq; Shayne F Andrew; Hermine A van Duyvenvoorde; Nicole S Verkaik; Monique Losekoot; Aleksey Porollo; Hernán Garcia; Yi Kuang; Dan Hanson; Peter Clayton; Dik C van Gent; Jan M Wit; Vivian Hwa; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

5.  Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

Authors:  D Moshous; I Callebaut; R de Chasseval; B Corneo; M Cavazzana-Calvo; F Le Deist; I Tezcan; O Sanal; Y Bertrand; N Philippe; A Fischer; J P de Villartay
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

6.  DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.

Authors:  Takashi Ochi; Andrew N Blackford; Julia Coates; Satpal Jhujh; Shahid Mehmood; Naoka Tamura; Jon Travers; Qian Wu; Viji M Draviam; Carol V Robinson; Tom L Blundell; Stephen P Jackson
Journal:  Science       Date:  2015-01-09       Impact factor: 47.728

7.  Ancient and recent adaptive evolution of primate non-homologous end joining genes.

Authors:  Ann Demogines; Alysia M East; Ji-Hoon Lee; Sharon R Grossman; Pardis C Sabeti; Tanya T Paull; Sara L Sawyer
Journal:  PLoS Genet       Date:  2010-10-21       Impact factor: 5.917

8.  A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

Authors:  Y Gao; Y Sun; K M Frank; P Dikkes; Y Fujiwara; K J Seidl; J M Sekiguchi; G A Rathbun; W Swat; J Wang; R T Bronson; B A Malynn; M Bryans; C Zhu; J Chaudhuri; L Davidson; R Ferrini; T Stamato; S H Orkin; M E Greenberg; F W Alt
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Mutations in the NHEJ component XRCC4 cause primordial dwarfism.

Authors:  Jennie E Murray; Mirjam van der Burg; Hanna IJspeert; Paula Carroll; Qian Wu; Takashi Ochi; Andrea Leitch; Edward S Miller; Boris Kysela; Alireza Jawad; Armand Bottani; Francesco Brancati; Marco Cappa; Valerie Cormier-Daire; Charu Deshpande; Eissa A Faqeih; Gail E Graham; Emmanuelle Ranza; Tom L Blundell; Andrew P Jackson; Grant S Stewart; Louise S Bicknell
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

Review 10.  The clinical impact of deficiency in DNA non-homologous end-joining.

Authors:  Lisa Woodbine; Andrew R Gennery; Penny A Jeggo
Journal:  DNA Repair (Amst)       Date:  2014-03-11
View more
  7 in total

Review 1.  The molecular basis and disease relevance of non-homologous DNA end joining.

Authors:  Bailin Zhao; Eli Rothenberg; Dale A Ramsden; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-19       Impact factor: 94.444

Review 2.  Nonhomologous DNA end-joining for repair of DNA double-strand breaks.

Authors:  Nicholas R Pannunzio; Go Watanabe; Michael R Lieber
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

Review 3.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

4.  NOVEL XRCC4 MUTATIONS IN AN INFANT WITH MICROCEPHALIC PRIMORDIAL DWARFISM, DILATED CARDIOMYOPATHY, SUBCLINICAL HYPOTHYROIDISM, AND EARLY DEATH: EXPANDING THE PHENOTYPE OF XRCC4 MUTATIONS.

Authors:  Meghan E Fredette; Kristin C Lombardi; Angela L Duker; Catherine O Buck; Chanika Phornphutkul; Michael B Bober; Jose Bernardo Quintos
Journal:  AACE Clin Case Rep       Date:  2019-08-28

5.  Functional analysis of XRCC4 mutations in reported microcephaly and growth defect patients in terms of radiosensitivity.

Authors:  Anie Day D C Asa; Rujira Wanotayan; Mukesh Kumar Sharma; Kaima Tsukada; Mikio Shimada; Yoshihisa Matsumoto
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

6.  The XRCC4 rs1805377 polymorphism is not associated with the risk of cancer: An updated meta-analysis.

Authors:  Xin-Yuan Zhang; Xiao-Han Wei; Bao-Jie Wang; Jun Yao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  An XRCC4 mutant mouse, a model for human X4 syndrome, reveals interplays with Xlf, PAXX, and ATM in lymphoid development.

Authors:  Benoit Roch; Vincent Abramowski; Olivier Etienne; Stefania Musilli; Pierre David; Jean-Baptiste Charbonnier; Isabelle Callebaut; François D Boussin; Jean-Pierre de Villartay
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.